Business Context and Reporting Period
Company: KindlyMD, Inc. (formerly Nakamoto Inc. in request metadata, but filing identifies KindlyMD, Inc.)
Reporting Period: Quarter ended September 30, 2025 (Q3 2025)
Business Model: The Company operates a dual strategy: (1) a legacy healthcare business focusing on holistic pain management and (2) a Bitcoin treasury strategy initiated via the August 14, 2025, merger with Nakamoto Holdings, Inc. The Company is classified as a non-accelerated filer, smaller reporting company, and emerging growth company.
Key Financial Metrics
| Metric | Q3 2025 (3 Months) | Q3 2024 (3 Months) | YTD 2025 (9 Months) | YTD 2024 (9 Months) |
|---|---|---|---|---|
| Revenue | $388,209 | $647,867 | $1,376,391 | $2,115,953 |
| Net Loss | $(86,035,808) | $(1,014,147) | $(89,487,606) | $(2,616,126) |
| Operating Expenses | $10,793,731 | $1,697,685 | $15,215,145 | $4,440,091 |
| Cash and Equivalents | $24,185,083 | $3,642,944 | $24,185,083 | $3,642,944 |
| Total Assets | $692,421,574 | $3,677,992 | $692,421,574 | $3,677,992 |
| Bitcoin Holdings (Fair Value) | $615,798,837 | $0 | $615,798,837 | $0 |
| Notes Payable (Current) | $203,017,500 | $139,277 | $203,017,500 | $139,277 |
Material Changes vs. Prior Period
- Merger and Asset Acquisition: On August 14, 2025, the Company completed a merger with Nakamoto Holdings, Inc. This was accounted for as an asset acquisition, resulting in a $59.8 million loss on acquisition due to the difference between consideration paid and net assets acquired (primarily driven by a put option liability).
- Bitcoin Treasury Strategy: The Company acquired 5,765 Bitcoin (cost basis ~$681M) and holds 5,398 units valued at ~$616M. This resulted in a $22.1 million unrealized loss and a $1.4 million realized loss on digital assets for the quarter.
- Debt Restructuring: The Company issued a $200M Convertible Debenture and a $203M Credit Facility. The Debenture was fully repaid in September 2025, triggering a $14.5 million loss on extinguishment of debt.
- Revenue Decline: Healthcare revenue decreased 40.1% QoQ to $388k, attributed to the closure of a Utah location and decreased cash-pay pricing, despite a 234.6% increase in insurance reimbursements.
- Equity Issuance: Significant dilution occurred via PIPE financings (~$540M raised) and the issuance of ~22.3M shares for the Nakamoto merger. Outstanding shares increased from ~6M (Dec 2024) to ~427M (Sep 2025).
Guidance, Outlook, Risks, and Contingencies
- Liquidity and Debt Maturity: The Company holds $24.2M in cash but faces a working capital deficit of ~$187M. A critical risk is the $206M Loan Agreement with Antalpha Digital Pte. Ltd., maturing December 6, 2025. The loan is secured by Bitcoin and requires maintaining a Loan-to-Value (LTV) ratio below 70%. A drop in Bitcoin price could trigger margin calls or default.
- Internal Controls: Management concluded that disclosure controls and procedures were not effective as of September 30, 2025, citing a material weakness in internal control over financial reporting (segregation of duties, lack of formalized risk assessment).
- Related Party Risks: The Company assumed a "Put Option Liability" related to BTC Inc. (a related party). The fair value of this liability decreased by $21.8M in Q3, providing a non-cash gain, but the obligation remains contingent on future events.
- Regulatory and Market Risks: Significant exposure to Bitcoin volatility, potential reclassification as an "investment company" under the Investment Company Act of 1940, and the risk of the Corporate Alternative Minimum Tax (CAMT) due to unrealized gains on Bitcoin.
Investor Verification Checklist
- Debt Covenants: Verify the current Bitcoin price relative to the $206M loan principal to assess the risk of a margin call or forced liquidation before the December 2025 maturity.
- Internal Control Remediation: Review the specific steps management is taking to remediate the material weakness in internal controls to ensure future financial reporting reliability.
- Put Option Liability: Confirm the terms of the BTC Inc. put option and the likelihood of exercise, as this liability significantly impacts the balance sheet and net income volatility.
- Healthcare Revenue Sustainability: Assess the long-term viability of the healthcare segment given the recent closure of locations and reliance on insurance reimbursements versus cash pay.
- Dilution Impact: Evaluate the impact of the massive increase in share count (from 6M to 427M) on future earnings per share and voting power.